Commensal bacteria educate immune tolerance and promote IgA production, IL-22 secretion (from ILC3s), and barrier function. Dysbiosis (reduced diversity, pathogenic expansion) alters immune education, weakens intestinal barriers, and is associated with inflammatory bowel disease, autoimmunity, and food allergies. Recolonization with specific commensals can restore tolerance and suppress autoimmunity, suggesting therapeutic opportunity.
Study specific commensals promoting Treg or Th17 differentiation (e.g., Faecalibacterium prausnitzii promoting Tregs). Examine how antibiotics disrupt immune homeostasis.
The microbiome is not simply 'part of the immune system'; it is a separate ecosystem that educates immunity. Dysbiosis does not universally impair immunity; some dysbiosis may enhance certain immune functions while weakening others.
From your study of mucosal immunity and immune tolerance, you know that the gut immune system faces a unique challenge: it must tolerate trillions of commensal bacteria in the intestinal lumen while remaining capable of responding to genuine pathogens. From your work on innate lymphoid cells, you know that ILC3s produce IL-22 to maintain epithelial barrier function. Microbiome-immune homeostasis describes the bidirectional relationship between the commensal microbial community and the host immune system — a relationship in which each side actively shapes the other.
Commensal bacteria are not passive bystanders tolerated by a permissive immune system. They actively educate immune development and function. Specific bacterial species promote the differentiation of particular immune cell subsets: for example, segmented filamentous bacteria (SFB) in the gut drive Th17 cell differentiation, while species of Clostridia (clusters IV and XIVa) and Bacteroides fragilis promote the development of regulatory T cells (Tregs) that suppress inflammatory responses. The polysaccharide A (PSA) produced by *B. fragilis* is directly recognized by immune cells and induces IL-10-producing Tregs. Meanwhile, commensal bacteria stimulate intestinal epithelial cells and dendritic cells to produce TSLP, TGF-β, and retinoic acid — signals that create a tolerogenic environment favoring Treg generation over inflammatory T cell activation.
The immune system reciprocally shapes the microbiome through secretory IgA, which is produced in enormous quantities at mucosal surfaces (3–5 grams per day in humans). IgA does not primarily function to kill bacteria — instead, it coats commensals, preventing them from breaching the epithelial barrier and confining them to the lumen. This process, called immune exclusion, maintains spatial segregation between bacteria and host tissue. ILC3-derived IL-22 reinforces this barrier by stimulating antimicrobial peptide production and tightening epithelial junctions. Together, IgA, antimicrobial peptides, and the mucus layer create a controlled boundary that permits mutualistic coexistence.
Dysbiosis — a disruption of normal microbial community composition, often caused by antibiotics, dietary changes, or illness — can destabilize this homeostatic balance. Reduced microbial diversity frequently leads to loss of Treg-promoting species, weakened barrier integrity, and increased translocation of bacterial products (like lipopolysaccharide) across the epithelium. This translocation triggers inflammatory responses through pattern recognition receptors, potentially driving chronic inflammation. Clinically, dysbiosis is associated with inflammatory bowel disease, where loss of tolerance to commensals drives destructive mucosal inflammation, and increasingly with systemic conditions including autoimmunity, allergies, and metabolic disease. The therapeutic implication is that restoring specific beneficial commensals — through targeted probiotics or fecal microbiota transplantation — can rebuild the tolerogenic signals needed to re-establish immune homeostasis.
No topics depend on this one yet.